Article Text

Download PDFPDF
Metastatic extragenital neoplasms to the uterus: a clinicopathologic study of four cases
  1. G. Giordano*,
  2. L. Gnetti*,
  3. R. Ricci*,
  4. C. Merisio and
  5. M. Melpignano
  1. * Departments of Pathology and Medicine of Laboratory, Section of Pathology, Parma University, Parma, Italy
  2. Departments of Obstetric and Gynecologic Sciences and Neonatology, Parma University, Parma, Italy
  1. Address correspondence and reprint requests to: Giovanna Giordano, MD, Dipartimento di Patologia e Medicina di Laboratorio, Sezione di Anatomia ed Istologia Patologica, Parma University, Viale A. Gramsci, 14, 43100 Parma, Italy. Email: giovanna.giordano{at}unipr.it

Abstract

The aim of this study was to elucidate the clinicopathologic features, the differential diagnostic problems, and the prognostic consequences of patients with metastatic extragenital malignancies to uterus. The patients with metastatic extragenital malignancies to the uterus were evaluated. We considered the metastases in non–genital tract organs at diagnosis of primary neoplasm, the distribution of the metastases in the uterus, and the presence of concomitant metastases in other genital and non–genital tract organs. There were four cases of metastatic extragenital malignancies to the uterus. The breast was the most frequent primary site (two cases: 50%). The other two primary tumors were adenocarcinoma of the cecum and malignant melanoma of the skin. The diagnosis was facilitated by clinical history, revealing the previous primary neoplasm, and by specific immunohistochemical study. Almost all the patients died from disseminated disease. Thus, the prognosis of metastatic extragenital malignancies to the uterus alone or simultaneously to the uterus and other organs of the genital tract is poor. Thus, the metastases to the uterus and to other organs of the genital tract can be considered a preterminal event.

  • adenocarcinoma of the cecum
  • breast carcinoma
  • female genital tract
  • malignant melanoma
  • metastatic extragenital neoplasms

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.